Search results
CRYOcheck LA Sure (Confirm), frozen
Dilute Russell's viper venom time (dRVVT) confirmatory reagent.
Bivalirudin (Angiox®) Plasma Calibrator
Calibrating the assays of bivalirudin using anti-IIa methods, especially with HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) or BIOPHEN DTI (ref. 220202).
Heparin Control, CRYOcheck (frozen)
Abnormal control for activated partial thromboplastin time (aPTT) assays.
Activated Protein C, Human
Recommended for studies concerning the protein C-protein S-thrombomodulin pathway, and for the activated protein C resistance assay, or any research protocols on factors Va and VIIIa.
Argatroban (Argatra®) Plasma Calibrator
Calibrating the assays of argatroban using clotting anti-IIa methods, especially when the HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) is used, with the low range protocol.
GFC Control Plasmas
Control plasmas for quick and efficient measurement of the Global Fibrinolytic Capacity with Hyphen BioMed's lysis timer .
FIBRIPHEN 5
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.
FIBRIPHEN 2
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.
FIBRIPHEN 1
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.
HEMOCLOT LA-S (Screen)
Reagent with low phospholipid concentration for lupus anticoagulants (LA) determination. The presence of LA prolongs clotting time.